PPARβ/δ attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells.

MLA

Zhang, Meijian, et al. “PPARβ/δ Attenuates Hepatic Fibrosis by Reducing SMAD3 Phosphorylation and P300 Levels via AMPK in Hepatic Stellate Cells.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 179, Oct. 2024, p. 117303. EBSCOhost, https://doi.org/10.1016/j.biopha.2024.117303.

APA

Zhang, M., Barroso, E., Peña, L., Rada, P., Valverde, Á. M., Wahli, W., Palomer, X., & Vázquez-Carrera, M. (2024). PPARβ/δ attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 179, 117303. https://doi.org/10.1016/j.biopha.2024.117303

Chicago

Zhang, Meijian, Emma Barroso, Lucía Peña, Patricia Rada, Ángela M Valverde, Walter Wahli, Xavier Palomer, and Manuel Vázquez-Carrera. 2024. “PPARβ/δ Attenuates Hepatic Fibrosis by Reducing SMAD3 Phosphorylation and P300 Levels via AMPK in Hepatic Stellate Cells.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 179 (October): 117303. doi:10.1016/j.biopha.2024.117303.